Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botticelli DVT Study: Apixaban vs Standard Therapy in Acute DVT
NCT00252005Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Nov 2005
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 2 trial of apixaban in deep vein thrombosis (DVT), sponsored by Bristol Myers Squibb. Started Nov 2005; status: completed.
02
Drugs
apixaban
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT00252005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00252005.